Skip to main content

6 Result(s)

within A. Kolstad Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials

    E Hoster, C H Geisler, J Doorduijn, B van der Holt, J Walewski, J Bloehdorn… in Leukemia (2016)

  2. No Access

    Article

    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation

    Reduced-intensity conditioning (RIC) allo-SCT is a potentially curative treatment approach for patients with relapsed Hodgkin’s or non-Hodgkin’s lymphoma. In the present study, 37 patients underwent RIC allo-S...

    Y Fløisand, L Brinch, T Gedde-Dahl, G E Tjønnfjord… in Bone Marrow Transplantation (2012)

  3. No Access

    Article

    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT

    A Kolstad, G Tjønnfjord, V Jønsson in Bone Marrow Transplantation (2008)

  4. No Access

    Article

    Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines

    The aim of this study was to investigate the late effects of ABMT on the immune system with regard to protective humoral immunity against common antigens and responses to recall antigens (vaccines). The vaccin...

    T Nordøy, A Husebekk, IS Aaberge, PA Jenum, HH Samdal… in Bone Marrow Transplantation (2001)

  5. No Access

    Article

    Response

    T Nordøy, A Kolstad, A Husebekk in Bone Marrow Transplantation (2000)

  6. No Access

    Article

    Persistent changes in the immune system 4–10 years after ABMT

    The aim of the present study was to investigate whether the early changes in the immune system observed after ABMT would persist over years. Eighty-five patients with malignant lymphoma were treated with ABMT ...

    T Nordøy, A Kolstad, P Endresen, H Holte, S Kvaløy… in Bone Marrow Transplantation (1999)